Adults 18 to 99, any sex, with Hearing Loss. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Sound Quality Ratings While StreamingPrimary· 60 minutes
Hearing aid recordings of different coupling options will be presented via a Multiple Stimuli with Reference and Anchor (MUSHRA) paradigm, where participants will rate and compare sound quality attributes between them.
Ratings will be made on a scale where 0 would the minimum value and 100 would be the maximum value.
Fullness: Higher scores indicate that participants found the recording to be fuller (thicker/richer sound). Higher scores indicate a better outcome.
Sharpness: Higher scores indicate that participants found the recording to be sharper (thinner/more shrill). Lower scores indicat
Hearing aid recordings of different listening situations through different coupling options will be presented via a Multiple Stimuli with Reference and Anchor (MUSHRA) paradigm, where participants will indicate preferences between different recordings.
Ratings will be made on a scale where 0 would the minimum value and 100 would be the maximum value. Higher scores indicate increased preferred sound quality.
Higher scores will indicate that participants had an increased preference towards that recording when compared to the other recordings. In this measure, on
State 2 - Mic Off - Music - Stream
Group
Value
95% CI
Sound Quality Ratings - Situational Preference
82.225
64 – 100
State 2 - Mic On - Music - Stream
Group
Value
95% CI
Sound Quality Ratings - Situational Preference
23.125
2 – 70
State 1 - Mic Off - Music - Stream
Group
Value
95% CI
Sound Quality Ratings - Situational Preference
50.35
6 – 99
State 1 - Mic On - Music - Stream
Group
Value
95% CI
Sound Quality Ratings - Situational Preference
21.95
2 – 59
State 2 - Mic Off - Speech - Stream
Group
Value
95% CI
Sound Quality Ratings - Situational Preference
84.225
9 – 98
State 2 - Mic On - Speech - Stream
Group
Value
95% CI
Sound Quality Ratings - Situational Preference
29.2
2 – 72
State 1 - Mic Off - Speech - Stream
Group
Value
95% CI
Sound Quality Ratings - Situational Preference
63.175
27 – 98
State 1 - Mic On - Speech - Stream
Group
Value
95% CI
Sound Quality Ratings - Situational Preference
28.925
2 – 72
Sponsor's own description
Evaluation of different hearing aid coupling methods including two states of a novel coupling method and two traditional coupling methods.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation
· NA
· recruiting
NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene
· NA
· recruiting
NCT07218913 — Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III
· Phase 1
· recruiting
NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit
· NA
· recruiting
NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
· NA
· recruiting
Other Sonova AG trials
Trials by the same sponsor.
NCT07526428 — Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary Assessment
· NA
· enrolling by invitation
NCT07501312 — Remote Microphone Performance Comparison in Adults With Hearing Loss
· NA
· enrolling by invitation
NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit
· NA
· recruiting
NCT06957730 — A Comparison of Hearing Aid Noise Programs on Speech Intelligibility
· NA
· completed
NCT06746038 — Evaluation of Extended Wear Hearing Aid for Mild Hearing Loss
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sonova AG
Last refreshed: 28 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05377359.